{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:28:39Z","timestamp":1793042919336,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clae.2024.102247","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:09:01Z","timestamp":1717477741000},"page":"102247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of autologous serum and platelet-rich plasma in the treatment of severe dry eye and persistent epithelial defects"],"prefix":"10.1016","volume":"47","author":[{"given":"\u0130brahim","family":"\u00d6zl\u00fck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"K\u00fcsbeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clae.2024.102247_b0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.clae.2024.102247_b0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archopht.1975.01010020815015","article-title":"Clinical experience with a mobile ocular perfusion pump","volume":"93","author":"Ralph","year":"1975","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102247_b0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","article-title":"Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca","volume":"27","author":"Fox","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.clae.2024.102247_b0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.clae.2024.102247_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bjophthalmol-2015-306842","article-title":"Blood-derived topical therapy for ocular surface diseases","volume":"100","author":"Soni","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102247_b0030","doi-asserted-by":"crossref","unstructured":"Liu L, Hartwig D, Harloff S, Herminghaus P, Wedel T, Geerling G. An optimised protocol for the production of autologous serum eyedrops. Graefe\u2019s Arch Clin Exp Ophthalmol 2005 9;243(7):706\u201314.","DOI":"10.1007\/s00417-004-1106-5"},{"issue":"2","key":"10.1016\/j.clae.2024.102247_b0035","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.clae.2024.102247_b0040","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/aos.12167","article-title":"Autologous serum eye drops diluted with sodium hyaluronate: clinical and experimental comparative study","volume":"92","author":"Lopez-Garcia","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.clae.2024.102247_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009327.pub2","article-title":"Autologous serum eye drops for dry eye","volume":"8","author":"Pan","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 Suppl 1","key":"10.1016\/j.clae.2024.102247_b0050","first-page":"3","article-title":"Growth factor content in PRP and their applicability in medicine","volume":"26","author":"Lubkowska","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"10.1016\/j.clae.2024.102247_b0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12891-022-05787-8","article-title":"Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial","volume":"23","author":"Nouri","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.clae.2024.102247_b0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.48095\/ccachp2021118","article-title":"Platelet-rich plasma improves esthetic postoperative outcomes of maxillofacial surgical procedures","volume":"63","author":"Menchisheva","year":"2021","journal-title":"Acta Chir Plast"},{"issue":"3","key":"10.1016\/j.clae.2024.102247_b0065","first-page":"163","article-title":"Persistent corneal epithelial defects: a review article","volume":"8","author":"Vaidyanathan","year":"2019","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102247_b0070","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1038\/s41598-022-12879-x","article-title":"Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease","volume":"12","author":"Metheetrairut","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.clae.2024.102247_b0075","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/138920112800624355","article-title":"The role of \u201ceye platelet rich plasma\u201d (eprp) for wound healing in ophthalmology","volume":"13","author":"Alio","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"10.1016\/j.clae.2024.102247_b0080","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2024.102247_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajo.2018.02.009","article-title":"Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases","volume":"189","author":"Ali","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102247_b0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefes Archive Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102247_b0095","doi-asserted-by":"crossref","DOI":"10.5935\/0034-7280.20170067","article-title":"The use of platelet rich-plasma in Ophthalmology: a literature review","volume":"76","author":"Ribeiro","year":"2017","journal-title":"Rev Bras Oftalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102247_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000100933","article-title":"Symptomatic dry eye treatment with autologous platelet-rich plasma","volume":"39","author":"Alio","year":"2007","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.clae.2024.102247_b0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study","volume":"6","author":"Alio","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.clae.2024.102247_b0110","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.clae.2024.102247_b0115","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1111\/aos.13907","article-title":"Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma","volume":"97","author":"Garcia-Conca","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.clae.2024.102247_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/826970","article-title":"Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies","volume":"2014","author":"Semeraro","year":"2014","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.clae.2024.102247_b0125","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.3390\/jcm12093126","article-title":"The Comparison between the composition of 100% autologous serum and 100% platelet-rich plasma eye drops and their \u0131mpact on the treatment effectiveness of dry eye disease in primary sjogren syndrome","volume":"12","author":"Wr\u00f3bel-Dudzi\u0144ska","year":"2023","journal-title":"J Clin Med"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T10:24:51Z","timestamp":1732011891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1367048424001395"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102247","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of autologous serum and platelet-rich plasma in the treatment of severe dry eye and persistent epithelial defects","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Contact Lens Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102247"}}